The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)-6-phenylimidazo[1,2-a]pyridine-3-carboxamide
ID: ALA1078739
PubChem CID: 46882707
Max Phase: Preclinical
Molecular Formula: C20H14ClN3O
Molecular Weight: 347.81
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1cnc2ccc(-c3ccccc3)cn12
Standard InChI: InChI=1S/C20H14ClN3O/c21-16-8-4-5-9-17(16)23-20(25)18-12-22-19-11-10-15(13-24(18)19)14-6-2-1-3-7-14/h1-13H,(H,23,25)
Standard InChI Key: HEAMMOPNKRHYGX-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
1.9152 -20.7041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9141 -21.5315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6289 -21.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6271 -20.2914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3425 -20.7005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3473 -21.5269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1348 -21.7778 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6167 -21.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1270 -20.4406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1440 -19.6175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8659 -19.2181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4372 -19.1921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4522 -18.3672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1786 -17.9712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1940 -17.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4888 -16.7280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7623 -17.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7505 -17.9474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0299 -18.3492 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.2028 -20.2920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2039 -19.4659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4902 -19.0536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2252 -19.4663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2223 -20.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4920 -20.7041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 12 1 0
2 3 2 0
12 13 1 0
3 6 1 0
13 14 2 0
1 2 1 0
14 15 1 0
5 4 1 0
15 16 2 0
6 7 2 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
18 19 1 0
9 5 1 0
4 1 2 0
20 21 2 0
9 10 1 0
21 22 1 0
5 6 1 0
22 23 2 0
10 11 2 0
23 24 1 0
24 25 2 0
25 20 1 0
1 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 347.81 | Molecular Weight (Monoisotopic): 347.0825 | AlogP: 4.91 | #Rotatable Bonds: 3 |
Polar Surface Area: 46.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.39 | CX LogP: 4.02 | CX LogD: 4.02 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.57 | Np Likeness Score: -1.66 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |